Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic ...

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

The key opportunities in the Global Personalized Medicine Biomarkers Market include advancements in genomic sequencing, growing reliance on targeted therapies, rising cancer and chronic disease ...

A review explores how next-generation sequencing may expand newborn screening and highlights key clinical and ethical challenges. Routine newborn screening (NBS) has transformed early disease ...

Ultima Genomics, Hamilton partner to enable improved lab operations to drive sequencing at scale: Fremont, California Saturday, February 28, 2026, 11:00 Hrs [IST] Ultima Genomics, ...

Generation Sequencing (NGS) market is set to surge from $14.79 billion in 2025 to $56.25 billion by 2033, with a robust CAGR of 18.17%. Key drivers include advancements in sequencing technologies, ...

A review explores how next-generation sequencing may expand newborn screening and highlights key clinical and ethical challenges. Every year, millions of newborns undergo routine screening as a ...

Transcriptomic landscape of Kaposi sarcoma: Insights into therapeutic targeting of KSHV. Pretreatment insights into primary sarcoma tissues using a novel approach of ex-vivo functional profiling to ...

We enrolled 50 patients undergoing resection of newly diagnosed (n = 15) or recurrent (n = 35) GBM. CSF was collected intraoperatively via the subarachnoid space (n = 25) or lateral ventricle (n = 25) ...